prednisolone has been researched along with Erysipelas in 5 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Erysipelas: An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.
| Excerpt | Relevance | Reference |
|---|---|---|
| "112 patients admitted to hospital with a diagnosis of erysipelas, were randomized to 8 days treatment with prednisolone or placebo in addition to antibiotics." | 9.08 | Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study. ( Bergkvist, PI; Sjöbeck, K, 1997) |
| "Of 112 patients with erysipelas, who were randomized to treatment with 8 d of either prednisolone or placebo in addition to antibiotics, 103 were followed-up for 12 months after they had been cured." | 9.08 | Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up. ( Bergkvist, PI; Sjöbeck, K, 1998) |
| "112 patients admitted to hospital with a diagnosis of erysipelas, were randomized to 8 days treatment with prednisolone or placebo in addition to antibiotics." | 5.08 | Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study. ( Bergkvist, PI; Sjöbeck, K, 1997) |
| "Of 112 patients with erysipelas, who were randomized to treatment with 8 d of either prednisolone or placebo in addition to antibiotics, 103 were followed-up for 12 months after they had been cured." | 5.08 | Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up. ( Bergkvist, PI; Sjöbeck, K, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krumbholz, A | 1 |
| Heinemann, C | 1 |
| Ziemer, M | 1 |
| Schreiber, G | 1 |
| Abendroth, B | 1 |
| Preussat, K | 1 |
| Peter, E | 1 |
| Bergkvist, PI | 2 |
| Sjöbeck, K | 2 |
| Cherkasov, VL | 1 |
| Schuhmachers, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Corticosteroids in Children Hospitalized With Cellulitis: Randomized, Double Blind, Placebo Controlled Trial[NCT02087527] | 19 participants (Actual) | Interventional | 2014-06-30 | Terminated (stopped due to Calculated sample size not achieved) | |||
| Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis[NCT01671423] | 42 participants (Actual) | Interventional | 2012-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of times the subject needed to use pain medication between day 1 and the 48 hour follow-up (NCT01671423)
Timeframe: Assessed once during the 48 hour follow-up
| Intervention | medications taken (Median) |
|---|---|
| Prednisone | 7 |
| Placebo | 2 |
The level of pain as measured by a Visual Analog Scale(VAS) measured once at day 1 and once during the 48th hour follow-up visit. Minimum value 0, maximum value 100mm, higher scores corresponds to more pain/worse outcomes. (NCT01671423)
Timeframe: Assessed once at day 1 and then once during the 48 hour follow-up
| Intervention | score on a scale (Mean) | |
|---|---|---|
| VAS at Day 1 | VAS at 48 hrs | |
| Placebo | 56.45 | 25.91 |
| Prednisone | 79.64 | 39.71 |
2 trials available for prednisolone and Erysipelas
| Article | Year |
|---|---|
Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study.
Topics: Anti-Inflammatory Agents; Bacteremia; Double-Blind Method; Drug Therapy, Combination; Erysipelas; Fe | 1997 |
Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study.
Topics: Anti-Inflammatory Agents; Bacteremia; Double-Blind Method; Drug Therapy, Combination; Erysipelas; Fe | 1997 |
Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study.
Topics: Anti-Inflammatory Agents; Bacteremia; Double-Blind Method; Drug Therapy, Combination; Erysipelas; Fe | 1997 |
Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study.
Topics: Anti-Inflammatory Agents; Bacteremia; Double-Blind Method; Drug Therapy, Combination; Erysipelas; Fe | 1997 |
Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Drug Therapy, Combination; Erysipelas; Follow-Up St | 1998 |
3 other studies available for prednisolone and Erysipelas
| Article | Year |
|---|---|
[Relapsing polychondritis as a rare different diagnosis of erysipelas].
Topics: Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Ear Diseases; Erysipelas; Female; Humans; P | 2004 |
[Current methods of treating patients with erysipelas].
Topics: Anti-Bacterial Agents; Erysipelas; Humans; Penicillins; Prednisolone; Prodigiosin; Recurrence; Strep | 1972 |
[Effect and side-effects of plastic injections].
Topics: Aged; Animals; Breast; Cosmetics; Erysipelas; Face; Female; Granuloma; Humans; Injections, Intraderm | 1965 |